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A Case Report of Clinical Application of Left Ventricular 
Assist Device for a Profound Left Ventricular Heart 
Failure After Open Heart Surgery 
NoBORU NISHIWAKI1), JuNICHIRO NISHIZAWAl), MASAHIKO MATSUMOTO町、 YUTAKA
KoNISHI1>, ToYOKAZU KoBAYASHJ2>, RYOJI vVATANABE2>, KAZUNOBU NISHIMURA3) 
Department of Cardiovascular Surgery, Wakayama Red Cross Hospital!), lst 
Department of Medicine, Wakayama Red Cross Hospital2>, Department 
of Cardiovascular Surgery, Faculty of Medicine, Kyoto University3) 
A 58ぅrear-oldman, who had refractory cardiogenic shock due to a ms>sive acute myocardial 
infarction, underwent em~rg己ncy operation of left ventricular aneurysmectomy and double 
aorta-coronary bypass grafcing tつth巴 lateralbranches of thき leftcircunfiex corona巧rartery. 
He developed profound lefc ventricular heart f.tilure (HF) and could not be weaned from cardi-
opulmonary bypass (CPB) in spite of assisted circulation with CPB and intraaortic balloon 
pumping (IABP) for the duration of 3 hours. 
LVAD (TOYOBO VAD system, thでpumpwith 70 ml of maximum stroke volume) was 
subsequently employed, and he was readily W己anedfrom CPB. 
During L V AD suppつrt,anticoagulation was not u3己d‘andhe was hemodynamically stable 
with bypass flow of 2.5 l/m/m2. However, his condition was complicated with acute renal 
failure necessitating a cr恒 tinuousarteriovenous hemofiltration and an overwhelming infection. 
Key words: Left ventricular asist device, Assisted circulation, Profound heart failure, Cardiogenic shock, Low 
cardiac output syndrome. 
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On the 10th postoperative day, septic shock developed suddenly, and he died despite of 
vigourous efforts. 
Recently, V AD has been realized to be the popular standard methods for such patients as 
the present case who are in profound HF and beyond the limit of IABP’s capability. But the 
long teロnresults are not yet gratifying. 
In conclusion, we would like to emphasize that the earlier emplo戸nentof V AD ismandatory 
to improve the systemic circulation and protect the patients with profound HF from multiple 









































術前現症：身長 158cm，体重 61kg，血圧 100/57
mm Hg，脈拍75整．貧血，黄症なし．肝牌腫認めず
四肢網状チアノーゼと冷感を認めた．
血液生化学所見： RBC465万， Hb13. 8 g/dl, Ht 
41. 5%, WBC 16, 700で貧血はないものの白血球増多
を認めた.GOT 36 IU, GPT 91 IU, T.Bil 0. 7 mg/di, 
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を装着す. VADは TOYOBO製 VADsestemで
ポンプは strokevolume 70 mlを用い（図－5），左房
脱血．上行大動脈送血である． これにて血圧 120/60








































RCA seg 2完全閉塞（上，矢印）， LAD seg 6完全閉家（下，矢印→）















藤田おらは IABP使用により 1時間の観察で血行動 より未だ壊死に陥っていない心筋の収縮力が回復し，
態に改善がみられないなら早期に VAD へ移行する 更に壊死に陥った心筋が VAD の使用により過伸展
乙とを勧めている．本症例はわれわれにとって VAD される乙とがないため強靭な結合繊生成が促され代償
装着の初めての経験であったが手技上何ら困難さは覚 能力を獲得すると考えられる．しかし彼らの実験報告
えず，また低用した TOYOBO製 VADsystemは抗 でも左室自由壁領域の80%以上の壊死巣を有するもの






























2/5 2/6 2/7 2/8 2/9 2/10 2/11 2/12 2/13 2/14 2/15 
MF F,02 1.0 1.0 0.8 0.5 0.5 0.5 0.5 0.5 0.6 0.6 0.6 0.6 0.6 
PH 7.45 7.49 7.46 7.55 7.56 7.52 7.43 7.43 7.49 7.52 7.50 7.52 7.51 
59y PC02 34 39 38 35 37 38 42 43 40 34 35 35 38 ~ P02 250 171 98 145 11 118 105 105 106 112 11 100 90 
CBG 同~寸LV Aneu (VT) (VT) (VT) (VT) (VF) (VT) (VT) (VF) 
くBleeding)
50 LVAO 
eo 93(Fixed) 83 83 83 0 rates 60 70 
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